A citation-based method for searching scientific literature

Irl B Hirsch, Kevin D O'Brien. Diabetes Technol Ther 2012
Times Cited: 6







List of co-cited articles
26 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
33

Hypoglycemia, diabetes, and cardiovascular disease.
Janet K Snell-Bergeon, R Paul Wadwa. Diabetes Technol Ther 2012
85
33

Cardiovascular disease in children and adolescents with diabetes: where are we, and where are we going?
Uyen T Truong, David M Maahs, Stephen R Daniels. Diabetes Technol Ther 2012
15
33


The glycocalyx and cardiovascular disease in diabetes: should we judge the endothelium by its cover?
Bregtje A Lemkes, Max Nieuwdorp, Joost B L Hoekstra, Frits Holleman. Diabetes Technol Ther 2012
23
33

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
33

Glucose control and vascular complications in veterans with type 2 diabetes.
William Duckworth, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D Reaven, Franklin J Zieve, Jennifer Marks, Stephen N Davis, Rodney Hayward,[...]. N Engl J Med 2009
33

Emerging economies and diabetes and cardiovascular disease.
Rajendra Pradeepa, Dorairaj Prabhakaran, Viswanathan Mohan. Diabetes Technol Ther 2012
30
33



10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
33

A randomized trial of therapies for type 2 diabetes and coronary artery disease.
Robert L Frye, Phyllis August, Maria Mori Brooks, Regina M Hardison, Sheryl F Kelsey, Joan M MacGregor, Trevor J Orchard, Bernard R Chaitman, Saul M Genuth, Suzanne H Goldberg,[...]. N Engl J Med 2009
33



Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the HORIZONS-AMI trial.
David Planer, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z Peruga, Bruce R Brodie, Ke Xu, Martin Fahy, Roxana Mehran, Gregg W Stone. Int J Cardiol 2013
46
33

Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI.
Christoph J Jensen, Holger C Eberle, Kai Nassenstein, Thomas Schlosser, Mani Farazandeh, Christoph K Naber, Georg V Sabin, Oliver Bruder. Clin Res Cardiol 2011
35
33

Intensive insulin therapy in critically ill patients.
G van den Berghe, P Wouters, F Weekers, C Verwaest, F Bruyninckx, M Schetz, D Vlasselaers, P Ferdinande, P Lauwers, R Bouillon. N Engl J Med 2001
33

Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction.
Abhinav Goyal, Shamir R Mehta, Rafael Díaz, Hertzel C Gerstein, Rizwan Afzal, Denis Xavier, Lisheng Liu, Prem Pais, Salim Yusuf. Circulation 2009
87
33


Glucose normalization and outcomes in patients with acute myocardial infarction.
Mikhail Kosiborod, Silvio E Inzucchi, Harlan M Krumholz, Frederick A Masoudi, Abhinav Goyal, Lan Xiao, Philip G Jones, Suzanne Fiske, John A Spertus. Arch Intern Med 2009
87
33

Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.
K Malmberg, L Rydén, H Wedel, K Birkeland, A Bootsma, K Dickstein, S Efendic, M Fisher, A Hamsten, J Herlitz,[...]. Eur Heart J 2005
705
33

Intensive versus conventional glucose control in critically ill patients.
Simon Finfer, Dean R Chittock, Steve Yu-Shuo Su, Deborah Blair, Denise Foster, Vinay Dhingra, Rinaldo Bellomo, Deborah Cook, Peter Dodek, William R Henderson,[...]. N Engl J Med 2009
33

U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction.
Duane S Pinto, Adam H Skolnick, Ajay J Kirtane, Sabina A Murphy, Hal V Barron, Robert P Giugliano, Christopher P Cannon, Eugene Braunwald, C Michael Gibson. J Am Coll Cardiol 2005
123
33

The association of admission blood glucose level with the clinical picture and prognosis in cardiogenic shock - Results from the CardShock Study.
Anu Kataja, Tuukka Tarvasmäki, Johan Lassus, Jose Cardoso, Alexandre Mebazaa, Lars Køber, Alessandro Sionis, Jindrich Spinar, Valentina Carubelli, Marek Banaszewski,[...]. Int J Cardiol 2017
23
33

Basal insulin and cardiovascular and other outcomes in dysglycemia.
Hertzel C Gerstein, Jackie Bosch, Gilles R Dagenais, Rafael Díaz, Hyejung Jung, Aldo P Maggioni, Janice Pogue, Jeffrey Probstfield, Ambady Ramachandran, Matthew C Riddle,[...]. N Engl J Med 2012
33

The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up.
F B Hu, M J Stampfer, C G Solomon, S Liu, W C Willett, F E Speizer, D M Nathan, J E Manson. Arch Intern Med 2001
350
16

Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004.
Kwok Leung Ong, Bernard M Y Cheung, Louisa Y F Wong, Nelson M S Wat, Kathryn C B Tan, Karen S L Lam. Ann Epidemiol 2008
186
16

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
16

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
16

Pioglitazone: mechanism of action.
U Smith. Int J Clin Pract Suppl 2001
111
16

Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.
Katherine Esposito, Dario Giugliano, Francesco Nappo, Raffaele Marfella. Circulation 2004
324
16

Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1.
E M Migoya, R Bergeron, J L Miller, R N K Snyder, M Tanen, D Hilliard, B Weiss, P Larson, M Gutierrez, G Jiang,[...]. Clin Pharmacol Ther 2010
129
16

Rosiglitazone RECORD study: glucose control outcomes at 18 months.
P D Home, N P Jones, S J Pocock, H Beck-Nielsen, R Gomis, M Hanefeld, M Komajda, P Curtis. Diabet Med 2007
60
16

Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?
J J Meier, B Gallwitz, W E Schmidt, A Mügge, M A Nauck. Heart 2004
84
16


Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
H C Gerstein, S Yusuf, J Bosch, J Pogue, P Sheridan, N Dinccag, M Hanefeld, B Hoogwerf, M Laakso, V Mohan,[...]. Lancet 2006
16


Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials.
C Lamanna, M Monami, N Marchionni, E Mannucci. Diabetes Obes Metab 2011
225
16

Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide.
H Klepzig, G Kober, C Matter, H Luus, H Schneider, K H Boedeker, W Kiowski, F W Amann, D Gruber, S Harris,[...]. Eur Heart J 1999
163
16


Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
Steven E Kahn, Steven M Haffner, Mark A Heise, William H Herman, Rury R Holman, Nigel P Jones, Barbara G Kravitz, John M Lachin, M Colleen O'Neill, Bernard Zinman,[...]. N Engl J Med 2006
16

A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes.
Robert Frederich, John H Alexander, Fred T Fiedorek, Mark Donovan, Niklas Berglind, Susan Harris, Roland Chen, Robert Wolf, Kenneth W Mahaffey. Postgrad Med 2010
175
16

Effects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitus.
Martin I Freed, Robert Ratner, Santica M Marcovina, Margaret M Kreider, Nandita Biswas, Beth R Cohen, John D Brunzell. Am J Cardiol 2002
189
16

Risk and short-term prognosis of myocardial infarction among users of antidiabetic drugs.
S P Johnsen, T B M Monster, M L Olsen, H Thisted, J K McLaughlin, H T Sørensen, H H Lervang, J Rungby. Am J Ther 2006
42
16

Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update.
Antonio Ceriello, Jamie Davidson, Markolf Hanefeld, Lawrence Leiter, Louis Monnier, David Owens, Naoko Tajima, Jaakko Tuomilehto. Nutr Metab Cardiovasc Dis 2006
102
16

Assessing the cardio-cerebrovascular safety of vildagliptin: meta-analysis of adjudicated events from a large Phase III type 2 diabetes population.
A Schweizer, S Dejager, J E Foley, A Couturier, M Ligueros-Saylan, W Kothny. Diabetes Obes Metab 2010
135
16


Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone.
David J Graham, Rita Ouellet-Hellstrom, Thomas E MaCurdy, Farzana Ali, Christopher Sholley, Christopher Worrall, Jeffrey A Kelman. JAMA 2010
366
16

Metformin reverses fatty liver disease in obese, leptin-deficient mice.
H Z Lin, S Q Yang, C Chuckaree, F Kuhajda, G Ronnet, A M Diehl. Nat Med 2000
530
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.